Nationwide Fund Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-7,450
| Closed | -$320K | – | 408 |
|
|
2017
Q3 | $320K | Hold |
7,450
| – | – | ﹤0.01% | 2408 |
|
|
2017
Q2 | $276K | Buy |
7,450
+249
| +3% | +$9.23K | ﹤0.01% | 2484 |
|
|
2017
Q1 | $390K | Sell |
7,201
-1,003
| -12% | -$54.3K | ﹤0.01% | 2280 |
|
|
2016
Q4 | $436K | Sell |
8,204
-434
| -5% | -$23.1K | ﹤0.01% | 2242 |
|
|
2016
Q3 | $523K | Sell |
8,638
-947
| -10% | -$57.3K | ﹤0.01% | 2160 |
|
|
2016
Q2 | $631K | Sell |
9,585
-3,253
| -25% | -$214K | ﹤0.01% | 2023 |
|
|
2016
Q1 | $728K | Buy |
12,838
+5,168
| +67% | +$293K | ﹤0.01% | 1882 |
|
|
2015
Q4 | $1.8M | Buy |
7,670
+1,400
| +22% | +$329K | 0.01% | 1413 |
|
|
2015
Q3 | $991K | Sell |
6,270
-1,755
| -22% | -$277K | ﹤0.01% | 1726 |
|
|
2015
Q2 | $3.04M | Sell |
8,025
-1,303
| -14% | -$493K | 0.01% | 1205 |
|
|
2015
Q1 | $3.9M | Buy |
9,328
+2,193
| +31% | +$917K | 0.02% | 1104 |
|
|
2014
Q4 | $1.95M | Buy |
7,135
+358
| +5% | +$98K | 0.01% | 1425 |
|
|
2014
Q3 | $1.32M | Buy |
6,777
+7
| +0.1% | +$1.36K | 0.01% | 1684 |
|
|
2014
Q2 | $1.66M | Buy |
6,770
+854
| +14% | +$209K | 0.01% | 1579 |
|
|
2014
Q1 | $1.57M | Sell |
5,916
-180
| -3% | -$47.7K | 0.01% | 1508 |
|
|
2013
Q4 | $2.21M | Sell |
6,096
-1,226
| -17% | -$445K | 0.01% | 1399 |
|
|
2013
Q3 | $3.89M | Buy |
7,322
+85
| +1% | +$45.2K | 0.02% | 1048 |
|
|
2013
Q2 | $1.7M | Buy |
+7,237
| New | +$1.7M | 0.01% | 1391 |
|